Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0002019410-26-000032
Filing Date
2026-04-23
Accepted
2026-04-23 06:23:57
Documents
26
Period of Report
2026-06-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A cai-20260423.htm   iXBRL DEF 14A 525540
3 cai-20260423_g1.jpg GRAPHIC 307449
4 cai-20260423_g10.jpg GRAPHIC 10961
5 cai-20260423_g11.jpg GRAPHIC 10447
6 cai-20260423_g12.jpg GRAPHIC 9756
7 cai-20260423_g13.jpg GRAPHIC 10170
8 cai-20260423_g14.jpg GRAPHIC 100262
9 cai-20260423_g15.jpg GRAPHIC 621472
10 cai-20260423_g16.jpg GRAPHIC 644288
11 cai-20260423_g2.jpg GRAPHIC 68679
12 cai-20260423_g3.jpg GRAPHIC 20713
13 cai-20260423_g4.jpg GRAPHIC 9846
14 cai-20260423_g5.jpg GRAPHIC 10542
15 cai-20260423_g6.jpg GRAPHIC 11542
16 cai-20260423_g7.jpg GRAPHIC 9857
17 cai-20260423_g8.jpg GRAPHIC 9721
18 cai-20260423_g9.jpg GRAPHIC 9411
  Complete submission text file 0002019410-26-000032.txt   5402338

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cai-20260423.xsd EX-101.SCH 941
29 EXTRACTED XBRL INSTANCE DOCUMENT cai-20260423_htm.xml XML 1114
Mailing Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039
Business Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039 (866) 771-8946
Caris Life Sciences, Inc. (Filer) CIK: 0002019410 (see all company filings)

EIN.: 852077369 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-42706 | Film No.: 26885426
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)